Fundraising Fox

Galya Blachman

Chief Legal Officer and Head of Business Development at Enliven Therapeutics

San Francisco, California, United States

Find your path to Galya

311 people in our graph share verified history with Galya — schools, employers, funds. One of them is your warm intro.

Anika GuptaunlockedGalya: together at 5AM Ventures (2020)
×4Galya: together at University of Oxford
×3Galya: together at 5AM Ventures
×2Galya: together at Enliven Therapeutics

Chief Legal Officer and Head of Business Development at Enliven Therapeutics

Intro paths

→

In turn, Galya can intro founders to Enliven Therapeutics's investors below.

Enliven Therapeutics's investors · 8

5AM VenturesBoston · $100K – $4M checksARCH Venture PartnersChicago · $50K – $250M checks · since 2024Bay City CapitalSan Rafael · $5M – $10M checksNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checksOrbiMedNew York · $1M – $75M checksPfizer Venture Investments$5M – $20M checksRA CapitalBostonRoche Venture FundBasel · $648K – $3.2M checks

Co-founders at Enliven Therapeutics

SK
Sam KintzCo-founder and Head of Pipeline
JL
Joe LyssikatosCo-founder and Research Fellow
AP
Anish PatelCo-founder and Chief Operating Officer

Experience

  1. Enliven TherapeuticsChief Legal Officer and Head of Business Developmentcurrent2023 — present
  2. Enliven TherapeuticsGeneral Counsel2020 — 2023San Francisco Bay Area
  3. Biotech Connection - Bay Area, Inc.Board Director and General Counsel2018 — 2025Bay Area, California
  4. 5AM VenturesLegal Advisor2023
  5. 5AM VenturesGeneral Counsel and Chief Compliance Officer; COO, 4:59 Initiative2022 — 2023San Francisco Bay Area
  6. 5AM VenturesGeneral Counsel and Chief Compliance Officer2020 — 2022San Francisco Bay Area
  7. AbbVieSenior Legal Counsel2017 — 2018South San Francisco, California
  8. Stemcentrx, Inc.Director, Legal2012 — 2017South San Francisco, California

Skills & more

Intellectual Property31Biochemistry4

Languages English · Hebrew

  • Galya Blachman — National Venture Capital Association

From Galya's professional profile.

Frequently asked questions

Who is Galya Blachman?
Chief Legal Officer and Head of Business Development at Enliven Therapeutics
Where does Galya Blachman work?
Galya Blachman is Chief Legal Officer and Head of Business Development at Enliven Therapeutics.
Where did Galya Blachman go to school?
Galya Blachman studied at United States Patent and Trademark Office (Patent Bar); University of Oxford (Graduate Diploma, Intellectual Property Law).

Same school

Also attended University of Oxford1,657

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 1,651 more

Shared employers

Also worked at Enliven Therapeutics5

Richard HeymanVenture Partner at ARCH Venture PartnersJake BauerVenture Partner at ARCH Venture PartnersMira ChaurushiyaManaging Director at Westlake Village BioPartnersJake BauerVenture Partner - US Investments/New Company Creation at SR One Capital ManagementBen HohlChief Financial Officer and Head of Corporate Development at Enliven Therapeutics

Also worked at Biotech Connection - Bay Area, Inc.10

Charles White, Ph.D.Principal at Illumina VenturesMira ChaurushiyaManaging Director at Westlake Village BioPartnersNaomi PacalinAssociate, Private Equity at Sofinnova VenturesEric HsuAnalyst, Private Equity at Sofinnova VenturesJack WangInsights Manager at McKesson VenturesGarrett DempseyInvestor at Endurance28

+ 4 more

Also worked at 5AM Ventures34

Anika GuptaInvestor at GV (Google Ventures)Susan LiuInvestment Team at 8VCGisella de la RochaVice President of Legal at MPM BioImpactMira ChaurushiyaManaging Director at Westlake Village BioPartnersLucy LiuPrincipal at Longwood FundKush M ParmarManaging Partner at 5AM Ventures

+ 28 more

Also worked at AbbVie51

Nick GasbarroChief of Staff at QED InvestorsCharles White, Ph.D.Principal at Illumina VenturesLaura QuockCBO-in-Residence at Versant VenturesManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next Ventures

+ 45 more